The University of Kansas Medical Center's Divisions of Medical Oncology and Hematologic Malignancy and Cellular Therapeutics (HMCT) offer a comprehensive three-year combined fellowship program. This program is accredited by the Accreditation Council for Graduate Medical Education (ACGME) and, upon successful completion, provides board eligibility in both hematology and medical oncology.

Our program is affiliated with the Kansas City Veterans Affairs Medical Center, where fellows spend 25% of their training time. In July 2025, we are excited to expand our training opportunities with the addition of Olathe Medical Center as a new partner site. This expansion allows us to accommodate a total of six fellows per year and introduces a dedicated Community Oncology Track for fellows interested in pursuing careers in community practice. This track is listed separately in the National Resident Matching Program (NRMP) account as “community track”

Clinical Training and Specialization

The fellowship program provides robust training in both outpatient and inpatient settings, emphasizing current best practices in the specialty. We prioritize outpatient care and continuity of care within an interactive multidisciplinary environment. Fellows are assigned to specialty-driven continuity clinics, fostering independence and patient ownership through prospective patient management. They also rotate through other specialty clinics in hematology and oncology, led by nationally recognized physicians who practice cutting-edge medicine with a strong focus on clinical trials and multidisciplinary care. Fellows in the Community Oncology Track will dedicate 20% of their time to Olathe Medical Center, gaining experience in a more general hematology-oncology program reflective of community practice.

Fellows receive hands-on exposure to one of the nation's largest stem cell transplant and cellular therapeutics programs. Other key strengths of our program include our nationally recognized Breast Cancer Prevention Program, a sophisticated early-phase clinical research program for drug development trials, and robust basic and translational research tracks.

Research and Scholarly Activity

All fellows receive one-on-one academic mentorship, with the expectation of significant scholarly activity. Fellows are encouraged to produce at least two manuscripts or national presentations during their third year.

The fellowship is an integral part of The University of Kansas Cancer Center, an NCI-Designated Comprehensive Cancer Center consistently ranked among the nation's top programs by U.S. News & World Report.

Fellows are expected to choose one of two tracks at the time of rank order list submission: the Clinical Track with Clinical Research or the Community Track. Fellows are expected to actively participate in and contribute significant time to research, including writing clinical trial protocols with faculty mentors. For fellows with prior experience or interest in translational or basic research, opportunities exist to dedicate substantial time in an appropriate basic or correlative research laboratory. The Clinical Research Track includes a dedicated block of time in the Phase I clinical research program to learn about early-phase trial development and patient enrollment.

A portion of the fellowship is dedicated to electives, including radiation therapy, blood banking, and palliative care. We are active members and participants in prominent national cooperative clinical trials groups, including the Southwest Oncology Group (SWOG), ASBMT, MPN-RC, and NRG Oncology.

Our faculty members possess diversified research interests spanning:

• Clinical Research (Phase II and Phase III programs)
• Phase I Research Program
• Translational and Basic Research in various fields
• Cancer Prevention Research

For more detailed information regarding our research program and fellowship training, please contact us directly.